Literature DB >> 22160551

Imipramine reverses depressive-like parameters in pneumococcal meningitis survivor rats.

Tatiana Barichello1, Graziele Milioli, Jaqueline S Generoso, Andreza L Cipriano, Caroline S Costa, Ana Paula Moreira, Márcia Carvalho Vilela, Clarissa M Comim, Antonio Lucio Teixeira, João Quevedo.   

Abstract

Pneumococcal meningitis is a severe infectious disease of the central nervous system, associated with acute inflammation and might cause damage to the host, such as deafness, blindness, seizure, and learning deficits. However, infectious diseases can play a significant role in the etiology of neuropsychiatric disturbances. In this context, we evaluated depressive-like parameters; corticosterone and ACTH levels in pneumococcal meningitis surviving rats. Wistar rats underwent a magna cistern tap receiving either 10 μL sterile saline or a Streptococcus pneumoniae suspension at the concentration of 5 × 10(9) cfu/mL. After 3 days of meningitis induction procedure, the animals were treated with imipramine at 10 mg/kg or saline for 14 days (3rd-17th day). The consumption of sweet food was measured for 7 days (10th-17th day). The meningitis group decreased the sucrose intake and increased the levels of corticosterone and ACTH levels in the serum and TNF-α in the cortex; however, the treatment with imipramine reverted the reduction of sweet food consumption, normalized hormonal levels and TNF-α in the cortex. Our results supported the hypothesis that the pneumococcal meningitis surviving rats showed depressive-like behavior and alterations in the hypothalamus-pituitary-adrenal axis.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22160551     DOI: 10.1007/s00702-011-0749-8

Source DB:  PubMed          Journal:  J Neural Transm (Vienna)        ISSN: 0300-9564            Impact factor:   3.575


  47 in total

1.  Correlation between behavioral deficits and decreased brain-derived neurotrophic [correction of neurotrofic] factor in neonatal meningitis.

Authors:  Tatiana Barichello; Eraldo Belarmino; Clarissa M Comim; Andreza L Cipriano; Jaqueline S Generoso; Geovana D Savi; Laura Stertz; Flávio Kapczinski; João Quevedo
Journal:  J Neuroimmunol       Date:  2010-05-08       Impact factor: 3.478

2.  Chronic treatment with imipramine and lithium increases cell proliferation in the hippocampus in adrenocorticotropic hormone-treated rats.

Authors:  Yoshihisa Kitamura; Maho Doi; Keiko Kuwatsuka; Yuka Onoue; Ikuko Miyazaki; Kazuaki Shinomiya; Toshihiro Koyama; Toshiaki Sendo; Hiromu Kawasaki; Masato Asanuma; Yutaka Gomita
Journal:  Biol Pharm Bull       Date:  2011       Impact factor: 2.233

3.  Admission cortisol and adrenocorticotrophic hormone levels in children with meningococcal disease: evidence of adrenal insufficiency?

Authors:  F A Riordan; A P Thomson; J M Ratcliffe; J A Sills; M J Diver; C A Hart
Journal:  Crit Care Med       Date:  1999-10       Impact factor: 7.598

4.  Prevention of brain injury by the nonbacteriolytic antibiotic daptomycin in experimental pneumococcal meningitis.

Authors:  Denis Grandgirard; Christian Schürch; Philippe Cottagnoud; Stephen L Leib
Journal:  Antimicrob Agents Chemother       Date:  2007-03-19       Impact factor: 5.191

5.  Depressive-like behavior induced by tumor necrosis factor-α in mice.

Authors:  Manuella P Kaster; Vinícius M Gadotti; João B Calixto; Adair R S Santos; Ana Lúcia S Rodrigues
Journal:  Neuropharmacology       Date:  2011-08-18       Impact factor: 5.250

6.  Imbalance between pro-inflammatory and anti-inflammatory cytokines in bipolar disorder.

Authors:  Yong-Ku Kim; Hyun-Gang Jung; Aye-Mu Myint; Hyun Kim; Sun-Hwa Park
Journal:  J Affect Disord       Date:  2007-04-16       Impact factor: 4.839

7.  Apoptosis of neurons in the dentate gyrus in humans suffering from bacterial meningitis.

Authors:  R Nau; A Soto; W Brück
Journal:  J Neuropathol Exp Neurol       Date:  1999-03       Impact factor: 3.685

8.  Immunocytochemical analysis of tumor necrosis factor and its receptors in Parkinson's disease.

Authors:  G Boka; P Anglade; D Wallach; F Javoy-Agid; Y Agid; E C Hirsch
Journal:  Neurosci Lett       Date:  1994-05-19       Impact factor: 3.046

9.  Association of serotype of Streptococcus pneumoniae with risk of severe and fatal outcome.

Authors:  Simon Rückinger; Rüdiger von Kries; Annette Siedler; Mark van der Linden
Journal:  Pediatr Infect Dis J       Date:  2009-02       Impact factor: 2.129

10.  An interleukin-1-alpha-like neuronal system in the preoptic-hypothalamic region and its induction by bacterial lipopolysaccharide in concentrations which alter pituitary hormone release.

Authors:  V Rettori; W L Dees; J K Hiney; K Lyson; S M McCann
Journal:  Neuroimmunomodulation       Date:  1994 Jul-Aug       Impact factor: 2.492

View more
  5 in total

1.  Association between Experimental Bacterial Meningitis and Periapical Lesion.

Authors:  Tatiana Barichello; Soraia Netto; Renan Antonio Ceretta; Jaqueline S Generoso; Lutiana R Simões; Patrícia Ávila Ribeiro; Josiane Budni; João Quevedo
Journal:  J Clin Diagn Res       Date:  2015-05-01

2.  Depression-Like Adult Behaviors may be a Long-Term Result of Experimental Pneumococcal Meningitis in Wistar Rats Infants.

Authors:  Tatiana Barichello; Lutiana R Simões; Jaqueline S Generoso; Vladislav S Sharin; Lucas B Souza; Luciano K Jornada; Diogo Dominguini; Samira S Valvassori; Antônio Lucio Teixeira; João Quevedo
Journal:  Neurochem Res       Date:  2016-06-30       Impact factor: 3.996

Review 3.  Glucocorticoids and the Brain after Critical Illness.

Authors:  Alice R Hill; Joanna L Spencer-Segal
Journal:  Endocrinology       Date:  2021-03-01       Impact factor: 4.736

4.  FAT/CD36: a major regulator of neuronal fatty acid sensing and energy homeostasis in rats and mice.

Authors:  Christelle Le Foll; Ambrose Dunn-Meynell; Serguei Musatov; Christophe Magnan; Barry E Levin
Journal:  Diabetes       Date:  2013-04-04       Impact factor: 9.461

5.  Synergistic effects of celecoxib and bupropion in a model of chronic inflammation-related depression in mice.

Authors:  Izaque S Maciel; Rodrigo B M Silva; Fernanda B Morrone; João B Calixto; Maria M Campos
Journal:  PLoS One       Date:  2013-09-27       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.